Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
ABT Abbott Laboratories weekly Stock Chart
ABT [NYSE]
Abbott Laboratories
Healthcare | Medical Appliances & Equipment | USA
financial highlights | statements
IndexS&P 500 P/E51.16 EPS (ttm)1.49 Insider Own0.70% Shs Outstand1.78B Perf Week0.00%
Market Cap135.24B Forward P/E21.11 EPS next Y3.60 Insider Trans-11.38% Shs Float1.75B Perf Month2.04%
Income2.63B PEG4.40 EPS next Q0.80 Inst Own76.00% Short Float0.75% Perf Quarter0.65%
Sales30.72B P/S4.40 EPS this Y34.30% Inst Trans-0.60% Short Ratio2.38 Perf Half Y7.49%
Book/sh17.54 P/B4.33 EPS next Y11.86% ROA3.80% Target Price83.06 Perf Year23.21%
Cash/sh1.83 P/C41.47 EPS next 5Y11.64% ROE8.50% 52W Range60.32 - 80.74 Perf YTD5.12%
Dividend1.28 P/FCF56.30 EPS past 5Y2.00% ROI6.10% 52W High-5.83% Beta1.11
Dividend %1.68% Quick Ratio1.10 Sales past 5Y9.20% Gross Margin58.40% 52W Low26.05% ATR1.48
Employees103000 Current Ratio1.60 Sales Q/Q2.00% Oper. Margin11.80% RSI (14)44.26 Volatility1.54% 1.79%
OptionableYes Debt/Eq0.62 EPS Q/Q39.20% Profit Margin8.50% Rel Volume0.69 Prev Close75.77
ShortableYes LT Debt/Eq0.61 EarningsApr 17 BMO Payout77.90% Avg Volume5.51M Price76.03
Recom1.90 SMA20-1.58% SMA50-2.40% SMA2005.47% Volume3,816,108 Change0.34%
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Oct-19-17Reiterated RBC Capital Mkts Outperform $55 → $60
Oct-06-17Resumed JP Morgan Neutral
Sep-28-17Reiterated Barclays Overweight $57 → $60
Aug-17-17Initiated Citigroup Neutral $53
Jun-29-17Resumed Jefferies Buy
Jun-29-17Initiated Guggenheim Buy $58
Jun-21-17Resumed BTIG Research Buy $56
May-16-17Initiated Goldman Neutral $45
May-21-19 04:02PM  The World's Top 10 Health Care Companies (UNH, MDT) Investopedia
10:45AM  TRILUMINATE Study Shows Treatment with Abbott's First-of-its-Kind Minimally Invasive Device Reduces Tricuspid Heart Valve Leaks PR Newswire
May-18-19 10:25AM  Should Abbott Laboratories (NYSE:ABT) Be Part Of Your Dividend Portfolio? Simply Wall St.
May-17-19 11:19AM  Most Important Mergers and Acquisitions of 2016 Investopedia
09:30AM  Why Is Abbott (ABT) Up 3.6% Since Last Earnings Report? Zacks
May-16-19 08:00AM  New ZonePerfect® Keto is 100% #TrueKeto with the Proven Blend of Macros for Effective Results PR Newswire
May-15-19 07:18AM  Nearly 9 out of 10 College Students with Student Debt Say It's Important to Find a Company That Offers Loan Relief PR Newswire
05:34AM  Bull of the Day: Penumbra (PEN) Zacks
May-14-19 10:07AM  Here are the stocks to buy if an all-out U.S.-China trade war erupts, says Goldman MarketWatch
09:00AM  Abbott Partners With NIH On BRAIN Initiative to Advance Research for Neurological Disorders PR Newswire
May-13-19 02:06PM  Is Pinterest a compelling buy? Is Abbott heading to new highs? The desk answers viewer questions CNBC Videos
10:37AM  Abbott Rides on Strong CGM, Poor Rhythm Management Ails Zacks
May-10-19 09:00AM  Abbott (ABT) Upgraded to Buy: What Does It Mean for the Stock? Zacks
May-09-19 10:28AM  The Zacks Analyst Blog Highlights: Verizon, Abbott, Illinois Tool Works, Moody's and Baker Hughes Zacks
May-08-19 02:03PM  Top Stock Reports for Verizon, Abbott & Illinois Tool Works Zacks
11:35AM  Haemonetics (HAE) Q4 Earnings Top Mark, Operating Margin Up Zacks
11:33AM  Bruker (BRKR) Q1 Earnings Beat Estimates, Guidance Upbeat Zacks
02:30AM  Nestle, rivals vie for big baby formula prize in China's smaller cities Reuters
May-07-19 07:30PM  Nestle, rivals vie for big baby formula prize in China's smaller cities Reuters
02:40PM  Nestle, rivals vie for big baby formula prize in China's smaller cities Reuters
01:48PM  Henry Schein's (HSIC) Q1 Earnings, Revenues Beat Estimates Zacks
09:05AM  Abbott Labs Falls 3% Investing.com
09:00AM  Abbott to Present at UBS Global Healthcare Conference PR Newswire
08:50AM  Intersect (XENT) Q1 Loss Wider Than Estimates, Revenues Top Zacks
08:15AM  QIAGEN's (QGEN) Q1 Earnings Top Estimates, Revenues Miss Zacks
08:05AM  Masimo (MASI) Q1 Earnings and Revenues Beat, Guidance Solid Zacks
06:05AM  Luminex (LMNX) Reports Q1 Loss, Misses Revenue Estimates Zacks
May-06-19 11:55AM  Surmodics (SRDX) Q2 Earnings and Revenues Beat Estimates Zacks
11:05AM  Fresenius Medical (FMS) Q1 Earnings & Revenues Top Estimates Zacks
10:05AM  HMS Holdings' (HMSY) Q1 Earnings and Revenues Beat Estimates Zacks
10:03AM  Integer Holdings (ITGR) Q1 Earnings & Revenues Top Estimates Zacks
09:49AM  AMN Healthcare (AMN) Q1 Earnings and Revenues Top Estimates Zacks
09:30AM  Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year? Zacks
09:00AM  Abbott Launches Next-generation Detection Technology in the U.S. and Europe, Offering a Smarter Approach to 24/7 Heart Monitoring for People with Irregular Heartbeats PR Newswire
04:27AM  Globus Medical (GMED) Q1 Earnings Miss, Revenues Grow Y/Y (Revised) Zacks
May-03-19 01:10PM  Abbott Ireland Financing DAC -- Moody's upgrades Abbott Laboratories' senior unsecured rating to A3, stable outlook Moody's
08:28AM  DENTSPLY SIRONA (XRAY) Q1 Earnings & Revenues Top Estimates Zacks
08:02AM  Insulet (PODD) Beats Earnings and Revenue Estimates in Q1 Zacks
07:10AM  Medidata (MDSO) Q1 Earnings Beat Estimates, Margins fall Zacks
06:55AM  PRA Health (PRAH) Q1 Earnings Beat Estimates, Revenues Miss Zacks
06:37AM  Globus Medical (GMED) Q1 Earnings Miss Mark, Margins Weak Zacks
06:19AM  ResMed's (RMD) Q3 Earnings Beat Estimates, Revenues in Line Zacks
04:48AM  Teleflex (TFX) Q1 Earnings Top Estimates, Margins Decline Zacks
May-02-19 11:40AM  Cardiovascular Systems (CSII) Q3 Earnings Top, View Tapered Zacks
11:37AM  NuVasive (NUVA) Q1 Earnings Top Estimates, Margins Strong Zacks
10:51AM  ABBOTT LABORATORIES (ABT) Q1 2019 Earnings Call Transcript Motley Fool
09:51AM  DexCom (DXCM) Beats on Q1 Earnings, Hikes '19 Guidance Zacks
09:38AM  AmerisourceBergen (ABC) Q2 Earnings Beat, Revenues Miss Zacks
08:54AM  Amedisys (AMED) Tops Earnings and Revenue Estimates in Q1 Zacks
08:49AM  ABIOMED (ABMD) Q4 Earnings Meet Estimates, Sales Rise in Japan Zacks
08:45AM  Hologic's (HOLX) Q2 Earnings Beat Estimates, Margins Fall Zacks
08:00AM  Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test PR Newswire
May-01-19 03:22PM  At US$78.27, Is It Time To Put Abbott Laboratories (NYSE:ABT) On Your Watch List? Simply Wall St.
11:42AM  CVS Health's (CVS) Q1 Earnings Top Estimates, EPS View Up Zacks
11:39AM  IDEXX (IDXX) Q1 Earnings Top Estimates, EPS Guidance Up Zacks
11:00AM  Tandem's (TNDM) Q1 Loss Wider Than Expected, Sales Top Mark Zacks
Apr-30-19 02:11PM  LabCorp (LH) Q1 Earnings Top Mark, Revenues Lag Estimates Zacks
10:28AM  Chemed (CHE) Q1 Earnings Miss Estimates, Revenues Grow Y/Y Zacks
09:57AM  Ecolab (ECL) Earnings Beat, Revenues Miss Estimates in Q1 Zacks
09:00AM  Abbott, the U.S. Department of Defense and TRACK-TBI Partner to Study Point-of-Care Blood Test for Concussions PR Newswire
Apr-29-19 11:35AM  Sen. Tina Smith Sells Entire Abbott Stock Investment Barrons.com
10:16AM  Hill-Rom's (HRC) Earnings and Revenues Top Estimates in Q2 Zacks
05:33AM  New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events in Adults with No Known Heart Disease PR Newswire
Apr-27-19 10:37PM  Weekly Top Insider Buys Highlight for the Week of April 26 GuruFocus.com
Apr-26-19 05:55PM  3 Dividend Aristocrats to Buy and Hold Forever Motley Fool
03:23PM  Zimmer Biomet's (ZBH) Q1 Earnings, Revenues Beat Estimates Zacks
11:59AM  Integra LifeSciences (IART) Q1 Earnings Beat, Margins Rise Zacks
11:55AM  Illumina (ILMN) Q1 Earnings Beat Estimates, Gross Margin Up Zacks
10:42AM  GNC Holdings (GNC) Reports Q1 Earnings, Revenues Down Y/Y Zacks
10:37AM  PerkinElmer (PKI) Beats on Q1 Earnings, Hikes '19 Guidance Zacks
09:55AM  Omnicell (OMCL) Earnings and Revenues Beat Estimates in Q1 Zacks
09:43AM  Cerner (CERN) Earnings and Revenues Meet Estimates in Q1 Zacks
05:58AM  Zacks.com featured highlights include: PepsiCo, Raymond James, Kansas City Southern, Fortive and Abbott Laboratories Zacks
Apr-25-19 10:45AM  Varian (VAR) Q2 Earnings Lag Estimates, Gross Orders Surge Zacks
09:48AM  Align Technology (ALGN) Beats on Q1 Earnings, Margins Down Zacks
08:37AM  Solid Sales Growth Makes These 5 Stocks Worth Buying Now Zacks
Apr-24-19 01:18PM  Final Trades: Boeing, Abbott Labs, Amarin & Disney CNBC Videos
Apr-20-19 05:00PM  How Marijuana Legalization Affected OrganiGram and Aphria's Latest Results Motley Fool
04:44PM  Bulls And Bears Of The Week: Abbott Labs, Chevron, CVS, United And More Benzinga
07:45AM  You can capture a dividend above 5% and still enjoy stock-market growth MarketWatch
Apr-19-19 01:38PM  Edited Transcript of ABT earnings conference call or presentation 17-Apr-19 1:00pm GMT Thomson Reuters StreetEvents
09:30AM  Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year? Zacks
Apr-18-19 01:40PM  A Diabetes Treatment Revolution Could Bolster These Medtech Firms Investor's Business Daily
11:18AM  An Abbott Labs Analyst's 5 Reasons To Own The Stock: 'Near-Perfect For This Environment' Benzinga
Apr-17-19 04:54PM  Here's Why Abbott Labs Stock Is Slipping Despite Its Quarterly Beat Investor's Business Daily
03:02PM  Abbott Labs Starts 2019 Off by Beating Expectations Motley Fool
01:25PM  Abbott Laboratories Jumps on 1st-Quarter Results GuruFocus.com
12:51PM  Stocks making the biggest moves midday: Qualcomm, Morgan Stanley, CSX & more CNBC
12:29PM  Abbott Laboratories Earnings: ABT Stock Down After Q1 Beat InvestorPlace
12:21PM  Abbott Labs quarterly beat overshadowed by unchanged forecast Reuters
12:02PM  Jim Cramer's Takeaway From Abbott's Earnings TheStreet.com
11:54AM  Abbott (ABT) Q1 Earnings Beat Estimates, Organic Sales Solid Zacks
11:28AM  Abbott Laboratories Reports Healthy First-Quarter Profit TheStreet.com
10:36AM  Abbott Labs beats first-quarter expectations on higher diabetes devices sales Reuters
10:14AM  Double Top Spells Trouble for 3 Health Care Stocks Investopedia
09:35AM  Jim Cramer Breaks Down Qualcomm, Netflix, and Abbott TheStreet.com
09:05AM  Abbott (ABT) Surpasses Q1 Earnings and Revenue Estimates Zacks
08:02AM  Abbott Labs' stock gains after profit and sales top forecasts, guidance is in line MarketWatch
07:53AM  Abbott: 1Q Earnings Snapshot Associated Press
07:50AM  Abbott Lab's first-quarter sales beat expectations Reuters
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. Its Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems for infectious diseases; molecular point-of-care care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company also provides glucose and blood glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watkin JaredSenior Vice PresidentMay 02Option Exercise46.18309,42914,290,631383,964May 06 05:04 PM
Watkin JaredSenior Vice PresidentMay 02Sale78.51309,42924,294,19974,535May 06 05:04 PM
Contreras JaimeSenior Vice PresidentApr 26Option Exercise38.4080,8603,105,024115,566Apr 29 05:35 PM
Contreras JaimeSenior Vice PresidentApr 25Option Exercise51.3082,7324,243,867117,438Apr 29 05:35 PM
Contreras JaimeSenior Vice PresidentApr 25Sale70.0082,7325,791,48734,706Apr 29 05:35 PM
Fussell Stephen RExecutive Vice PresidentApr 23Option Exercise47.0056,0002,632,000225,935Apr 24 05:10 PM
Fussell Stephen RExecutive Vice PresidentApr 23Sale76.0056,0004,256,000169,935Apr 24 05:10 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentApr 22Buy73.402,000146,79852,562Apr 24 05:05 PM
Contreras JaimeSenior Vice PresidentApr 22Sale73.1291867,1242,227Apr 24 05:06 PM
MANNING JOSEPH JSenior Vice PresidentMar 20Sale79.585,613446,66550,529Mar 21 05:10 PM
WHITE MILES DChairman and CEOMar 18Option Exercise24.29589,70014,324,3233,763,865Mar 20 05:29 PM
WHITE MILES DChairman and CEOMar 18Sale78.5576,0695,974,9893,174,165Mar 20 05:33 PM
WHITE MILES DChairman and CEOMar 18Sale78.5281,5806,405,7813,326,190Mar 20 05:31 PM
WHITE MILES DChairman and CEOMar 18Sale78.5775,9565,967,8373,250,234Mar 20 05:31 PM
WHITE MILES DChairman and CEOMar 18Sale78.6274,2225,835,4013,613,904Mar 20 05:29 PM
WHITE MILES DChairman and CEOMar 18Sale78.5176,7196,023,1533,537,185Mar 20 05:30 PM
WHITE MILES DChairman and CEOMar 18Sale78.65128,31510,092,3573,408,870Mar 20 05:31 PM
WHITE MILES DChairman and CEOMar 18Sale78.6175,7395,953,9543,688,126Mar 20 05:29 PM
BIRD ROGERSenior Vice PresidentMar 13Sale79.069,188726,41659,807Mar 14 05:01 PM
Bracken Sharon JSenior Vice PresidentMar 06Sale77.835,500428,07444,919Mar 08 05:07 PM
YOOR BRIAN BExecutive Vice President & CFOMar 01Sale78.002,246175,188114,381Mar 04 05:35 PM
Watkin JaredSenior Vice PresidentMar 01Sale78.001,391108,49874,535Mar 04 05:33 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 01Sale78.001,664129,792106,748Mar 04 05:32 PM
MANNING JOSEPH JSenior Vice PresidentMar 01Sale78.001,22395,39456,142Mar 04 05:30 PM
Fussell Stephen RExecutive Vice PresidentMar 01Sale78.002,246175,188169,935Mar 04 05:26 PM
Funck Robert ESenior Vice PresidentMar 01Sale78.001,00278,156138,991Mar 04 05:24 PM
Contreras JaimeSenior Vice PresidentMar 01Sale78.2812,561983,286103,446Mar 04 05:23 PM
Blaser Brian JExecutive Vice PresidentMar 01Sale78.2316,1551,263,737130,745Mar 04 05:18 PM
Bracken Sharon JSenior Vice PresidentMar 01Sale78.001,22495,47250,419Mar 04 05:19 PM
BRYNELSEN CHARLESSenior Vice PresidentMar 01Sale78.001,00278,15641,111Mar 04 05:21 PM
ALLEN HUBERT LExecutive Vice PresidentMar 01Sale78.002,246175,188146,010Mar 04 05:17 PM
BIRD ROGERSenior Vice PresidentMar 01Sale78.001,11386,81468,995Mar 04 05:18 PM
Contreras JaimeSenior Vice PresidentJan 31Option Exercise42.24140,1505,920,120231,798Feb 01 05:44 PM
Stratton John GDirectorJan 31Buy72.323,455249,8756,400Feb 01 05:43 PM
Contreras JaimeSenior Vice PresidentJan 30Option Exercise43.06214,1379,220,941269,105Feb 01 05:44 PM
Contreras JaimeSenior Vice PresidentJan 30Sale70.00177,45712,421,99091,648Feb 01 05:44 PM
WHITE MILES DChairman and CEONov 28Option Exercise26.02325,0008,454,8753,459,185Nov 30 05:02 PM
WHITE MILES DChairman and CEONov 28Sale72.585,519400,5823,134,185Nov 30 05:03 PM
WHITE MILES DChairman and CEONov 28Sale72.35142,34110,298,6103,316,844Nov 30 05:02 PM
WHITE MILES DChairman and CEONov 28Sale72.49177,14012,840,5983,139,704Nov 30 05:03 PM
Watkin JaredSenior Vice PresidentNov 02Option Exercise38.4065,0002,496,000128,640Nov 06 05:08 PM
Watkin JaredSenior Vice PresidentNov 02Sale71.0065,0004,615,00063,640Nov 06 05:08 PM
Bracken Sharon JSenior Vice PresidentSep 28Sale73.351,732127,04439,029Oct 02 06:58 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentSep 28Sale73.395,000366,95788,521Oct 02 06:58 PM
Blaser Brian JExecutive Vice PresidentSep 20Option Exercise27.4358,2001,596,165195,018Sep 21 05:02 PM
Blaser Brian JExecutive Vice PresidentSep 20Sale68.7958,2004,003,862136,818Sep 21 05:02 PM
Funck Robert ESenior Vice PresidentSep 05Option Exercise25.2436,400918,727145,080Sep 07 05:15 PM
Contreras JaimeSenior Vice PresidentAug 29Option Exercise37.67172,4686,496,984222,904Aug 31 05:04 PM
Contreras JaimeSenior Vice PresidentAug 29Sale66.8464,2684,295,39554,968Aug 31 05:05 PM
Contreras JaimeSenior Vice PresidentAug 29Sale66.7495,7936,393,590127,111Aug 31 05:04 PM
LANE ANDREW HExecutive Vice PresidentAug 29Sale67.119,097610,51326,583Aug 31 05:03 PM
Bracken Sharon JSenior Vice PresidentJul 30Sale65.1661540,07340,761Jul 31 05:01 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Option Exercise26.0264,9001,688,374363,200Jul 26 05:05 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Sale65.0064,9004,218,500298,300Jul 26 05:05 PM
Blaser Brian JExecutive Vice PresidentJul 24Sale63.9615,100965,789136,818Jul 26 05:09 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 24Sale63.5080350,99178,417Jul 24 05:02 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 23Sale63.2024715,61079,220Jul 24 05:02 PM
Bracken Sharon JSenior Vice PresidentJul 23Sale63.2025916,36941,376Jul 24 05:01 PM
Funck Robert ESenior Vice PresidentJun 05Option Exercise26.0212,800332,992117,293Jun 07 05:08 PM
open in yahoo | open in reuters | open in google